Search Results 81-90 of 16558 for Mmol

1. Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients - Mayo Clinic

   Corrected serum calcium superior to 14 mg per dL (superior to 3.5 mmol per L). Aspartate aminotransferase (AST) and/or Alanine Aminotransferase (ALT) ...

2. Sed rate (erythrocyte sedimentation rate) - Mayo Clinic

   Sed rate is a blood test that can reveal inflammatory activity in your body. It's often used to help diagnose conditions affecting your joints or muscles.

3. Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure - Mayo Clinic

   Serum K+ ≤5.0 mmol/L at enrollment; NT-proBNP ≥1000 pg/mL or BNP ≥250 pg/mL, measured within 24h from randomization; Not on MRA or on low-dose ...

4. A Study to Evaluate the Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

   Potassium < 3.7 mmol/l or > 5.5 mmol/l at screening. Severe renal impairment (creatinine clearance < 30 ml/min at screening), creatinine > 170 μmol/l at ...

5. Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Serum calcium corrected for albumin >14.0 mg/dL (> 3.5 mmol/L), or free ionized calcium 6.5 mg/dL (> 1.6 mmol/L). Subject has known allergies ...

6. A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) - Mayo Clinic

   Serum sodium levels < 130 mmol/L or >145 mmol/L. Taking any other experimental medications. Require ventilator support. Taking medications known to induce ...

7. Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation - Mayo Clinic

   - Donor terminal serum Na >160 mmol/L Donation after Cardio-circulatory Death (DCD) Liver Inclusion Criteria (all): - Donor age 18-60 years - Anticipated ...

8. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS - Mayo Clinic

   Potassium < 3.7 mmol/l or > 5.5 mmol/l at screening. Severe renal impairment (creatinine clearance < 30 ml/min at screening), creatinine > 170 μmol/l at ...

9. Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of DCR-PHXC Solution for Injection (subcutaneous use) in Patients with Primary Hyperoxaluria - PHYOX 2 - Mayo Clinic

   ... mmol (adjusted per 1.73 m2 BSA in participants aged < 18 years). Less than 20% variation between the two 24-hour urinary creatinine excretion values [mmol ...

10. Encaleret Compared to Standard of Care in Participants with Autosomal Dominant Hypocalcemia Type 1 - Mayo Clinic

    Participation eligibility · cCa < 8.6 mg/dL (2.2 mmol/L) in participants 16 to < 18 years, or < 8.5 mg/dL (2.1 mmol/L) in participants ≥ 18 years iPTH < 40 pg/ ...